Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Wadenvik%2C+Hans%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Wadenvik%2C+Hans%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2022
Mark Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per ; Flygt, Hjalmar ; Richter, Johan ^LU ; Olsson-Strömberg, Ulla ; Wadenvik, Hans ; Dreimane, Arta ; Myhr-Eriksson, Kristina and Zhao, Jingcheng , et al. (2022) In American Journal of Hematology 97(4). p.421-430
- Contribution to journal › Article
2021
Mark Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten ; Dremaine, Arta ; Lübking, Anna ^LU ; Markevärn, Berit ; Myhr-Eriksson, Kristina ; Olsson, Karin ; Olsson-Strömberg, Ulla and Själander, Anders , et al. (2021) In British Journal of Haematology 193(5). p.915-921
- Contribution to journal › Article
2017
Mark No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia : A population-based study in Sweden
Gunnarsson, Niklas ; Höglund, M. ; Stenke, L ; Sandin, F. ; Björkholm, M ; Dreimane, Arta ; Lambe, M. ; Markevärn, Berit ; Olsson-Strömberg, Ulla and Wadenvik, Hans , et al. (2017) In Leukemia 31(8). p.1825-1827
- Contribution to journal › Letter
Mark Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
Söderlund, Stina ; Dahlén, Torsten ; Sandin, Fredrik ; Olsson-Strömberg, Ulla ; Creignou, Maria ; Dreimane, Arta ; Lübking, Anna ^LU ; Markevärn, Berit ; Själander, Anders and Wadenvik, Hans , et al. (2017) In European Journal of Haematology 98(1). p.57-66
- Contribution to journal › Article
2016
Mark IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Ågerstam, Helena ^LU ; Hansen, Nils ^LU ; von Palffy, Sofia ^LU ; Sandén, Carl ^LU ; Reckzeh, Kristian ^LU ; Karlsson, Christine ^LU ; Lilljebjörn, Henrik ^LU ; Landberg, Niklas ^LU ; Askmyr, Maria ^LU and Högberg, Carl ^LU , et al. (2016) In Blood 128(23). p.2683-2693
- Contribution to journal › Article
2015
Mark Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
Gunnarsson, Niklas ; Stenke, Leif ; Hoglund, Martin ; Sandin, Fredrik ; Bjorkholm, Magnus ; Dreimane, Arta ; Lambe, Mats ; Markevarn, Berit ; Olsson-Stromberg, Ulla and Richter, Johan ^LU , et al. (2015) In British Journal of Haematology 169(5). p.683-688
- Contribution to journal › Article
2013
Mark Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
Hoglund, Martin ; Sandin, Fredrik ; Hellstrom, Karin ; Bjoreman, Mats ; Bjorkholm, Magnus ; Brune, Mats ; Dreimane, Arta ; Ekblom, Marja ^LU ; Lehmann, Soren and Ljungman, Per , et al. (2013) In Blood 122(7). p.1284-1292
- Contribution to journal › Article

your query:: Remove author: Wadenvik, Hans